Formulations and methods of administration of cephalotaxines, including homoharringtonine
AssigneeChemGenex Pharmaceuticals, Inc.
InventorDennis M. Brown
Life of this patent
Estimating the term…
Abstract
The present invention is directed to compositions and methods for the treatment of patients with cephalotaxines, for example, homoharringtonine. The invention is also directed to improvements in the purity, manufacturing process, formulation and administration of homoharringtonine for the treatment of cancer and other aberrant cellular diseases. The invention also provides methods and compositions for antiparasitic, antifungal, antiviral and antibacterial treatments.
Claims14
A sealed container consisting essentially of an aqueous solution of homoharringtonine (4-methyl-2-hydroxy-2-(4-hydroxy-4-methylpentyl) (HHT), wherein said solution is free of pharmaceutical excipients and said sealed container is an ampoule or a vial.
A sealed container consisting essentially of an aqueous solution of homoharringtonine (4-methyl-2-hydroxy-2-(4-hydroxy-4-methylpentyl) (HHT) in a dosage form free of pharmaceutical excipients, wherein said HHT is a tartrate salt of HHT and said sealed container is an ampoule or a vial.
Dependencies are inferred from the claim text.